Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
7 of the Best Pharma Stocks to Buy Now
10:37am, Tuesday, 11'th May 2021
As the market gets back to normal, it's a great time to explore the pharma stocks that got lost in the vaccine frenzy of the past year. The post 7 of the Best Pharma Stocks to Buy Now appeared first o
Horizon's (HZNP) Q1 Earnings Miss Estimates, Revenues Beat
08:16am, Thursday, 06'th May 2021
Horizon (HZNP) misses estimates for earnings in the first quarter of 2021 while revenues beat the same.
Horizon Therapeutics' (HZNP) CEO Tim Walbert on Q1 2021 Results - Earnings Call Transcript
01:23pm, Wednesday, 05'th May 2021
Horizon Therapeutics' (HZNP) CEO Tim Walbert on Q1 2021 Results - Earnings Call Transcript
Horizon Therapeutics (HZNP) Misses Q1 Earnings Estimates
09:24am, Wednesday, 05'th May 2021
Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of -57.14% and 4.88%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Horizon Therapeutics Q1 Earnings
07:21am, Wednesday, 05'th May 2021
Shares of Horizon Therapeutics (NASDAQ:HZNP) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were down 92.50% year over year to $0.03, which missed the estim
Analysts Estimate Horizon Therapeutics (HZNP) to Report a Decline in Earnings: What to Look Out for
01:47pm, Wednesday, 28'th Apr 2021
Horizon Therapeutics (HZNP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
07:30am, Wednesday, 21'st Apr 2021
CHARLOTTESVILLE, Va., April 21, 2021 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has identified a second drug target for the treatment of gout
Forbion Announces Final Close of Forbion Growth Opportunities Fund I at EUR 360 Million (USD 428 Million)
04:04am, Tuesday, 20'th Apr 2021
NAARDEN, The Netherlands & MUNICH--(BUSINESS WIRE)--Forbion, a leading European life sciences venture capital firm, today announces the final close of its Forbion Growth Opportunities Fund I (“Forbi
3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To
06:33am, Saturday, 17'th Apr 2021
Horizon Therapeutics's shares are up almost 200% over the past 12 months, buoyed by mind-boggling sales of its new blockbuster drug.
New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
08:30am, Friday, 16'th Apr 2021
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics today announced new UPLIZNA® (inebilizumab-cdon) data being presented at the American Academy of Neurology 2021 Annual Meeting.
Does 2021's Best Biopharma to Work for Belong in Your Portfolio?
06:10am, Wednesday, 07'th Apr 2021
Horizon Therapeutics has a clear path to significant sales growth.
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announces new NMOSD data being presented at the American Academy of Neurology's 73rd Annual Meeting.
HZNP Stock Price Increased 8.67%: Why It Happened
10:45pm, Tuesday, 30'th Mar 2021
The stock price of Horizon Therapeutics PLC (NASDAQ: HZNP) increased by 8.67% today. This is why it happened.
Horizon Therapeutics and Chicago Cubs Announce Legacy Partnership
10:05am, Monday, 29'th Mar 2021
DEERFIELD, Ill.--(BUSINESS WIRE)--Horizon Therapeutics (Nasdaq: HZNP) and the Cubs today announced a Legacy Partnership that includes a Cubs STEAM Program, presented by Horizon, which will include an
Why Is Horizon Therapeutics (HZNP) Down 8.1% Since Last Earnings Report?
12:07pm, Friday, 26'th Mar 2021
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
